Literature DB >> 27738108

Coordinated Activities of Multiple Myc-dependent and Myc-independent Biosynthetic Pathways in Hepatoblastoma.

Huabo Wang1, Jie Lu1, Lia R Edmunds1, Sucheta Kulkarni1, James Dolezal1, Junyan Tao2, Sarangarajan Ranganathan3, Laura Jackson4, Marc Fromherz1, Donna Beer-Stolz5, Radha Uppala6, Sivakama Bharathi6, Satdarshan P Monga2,7, Eric S Goetzman6, Edward V Prochownik8,9,10.   

Abstract

Hepatoblastoma (HB) is associated with aberrant activation of the β-catenin and Hippo/YAP signaling pathways. Overexpression of mutant β-catenin and YAP in mice induces HBs that express high levels of c-Myc (Myc). In light of recent observations that Myc is unnecessary for long-term hepatocyte proliferation, we have now examined its role in HB pathogenesis using the above model. Although Myc was found to be dispensable for in vivo HB initiation, it was necessary to sustain rapid tumor growth. Gene expression profiling identified key molecular differences between myc+/+ (WT) and myc-/- (KO) hepatocytes and HBs that explain these behaviors. In HBs, these included both Myc-dependent and Myc-independent increases in families of transcripts encoding ribosomal proteins, non-structural factors affecting ribosome assembly and function, and enzymes catalyzing glycolysis and lipid bio-synthesis. In contrast, transcripts encoding enzymes involved in fatty acid β-oxidation were mostly down-regulated. Myc-independent metabolic changes associated with HBs included dramatic reductions in mitochondrial mass and oxidative function, increases in ATP content and pyruvate dehydrogenase activity, and marked inhibition of fatty acid β-oxidation (FAO). Myc-dependent metabolic changes included higher levels of neutral lipid and acetyl-CoA in WT tumors. The latter correlated with higher histone H3 acetylation. Collectively, our results indicate that the role of Myc in HB pathogenesis is to impose mutually dependent changes in gene expression and metabolic reprogramming that are unattainable in non-transformed cells and that cooperate to maximize tumor growth.
© 2016 by The American Society for Biochemistry and Molecular Biology, Inc.

Entities:  

Keywords:  Myc (c-Myc); beta-catenin (B-catenin); hepatocellular carcinoma; metabolism; oxidative phosphorylation; yes-associated protein (YAP)

Mesh:

Substances:

Year:  2016        PMID: 27738108      PMCID: PMC5159488          DOI: 10.1074/jbc.M116.754218

Source DB:  PubMed          Journal:  J Biol Chem        ISSN: 0021-9258            Impact factor:   5.157


  49 in total

1.  Mitochondrial DNA copy number is regulated by cellular proliferation: a role for Ras and p66(Shc).

Authors:  Mirella Trinei; Ina Berniakovich; Pier Giuseppe Pelicci; Marco Giorgio
Journal:  Biochim Biophys Acta       Date:  2006-05-25

2.  Hippo/YAP, β-catenin, and the cancer cell: a "ménage à trois" in hepatoblastoma.

Authors:  Karl G Sylvester; Sabine Colnot
Journal:  Gastroenterology       Date:  2014-07-27       Impact factor: 22.682

3.  Analysis of C-MYC function in normal cells via conditional gene-targeted mutation.

Authors:  I M de Alboran; R C O'Hagan; F Gärtner; B Malynn; L Davidson; R Rickert; K Rajewsky; R A DePinho; F W Alt
Journal:  Immunity       Date:  2001-01       Impact factor: 31.745

Review 4.  Dysregulation of Wnt/β-catenin signaling in gastrointestinal cancers.

Authors:  Bryan D White; Andy J Chien; David W Dawson
Journal:  Gastroenterology       Date:  2011-12-08       Impact factor: 22.682

5.  Promotion of growth and apoptosis in c-myc nullizygous fibroblasts by other members of the myc oncoprotein family.

Authors:  M Landay; S K Oster; F Khosravi; L E Grove; X Yin; J Sedivy; L Z Penn; E V Prochownik
Journal:  Cell Death Differ       Date:  2000-08       Impact factor: 15.828

Review 6.  MYC, Metabolism, and Cancer.

Authors:  Zachary E Stine; Zandra E Walton; Brian J Altman; Annie L Hsieh; Chi V Dang
Journal:  Cancer Discov       Date:  2015-09-17       Impact factor: 39.397

Review 7.  Rethinking the Warburg effect with Myc micromanaging glutamine metabolism.

Authors:  Chi V Dang
Journal:  Cancer Res       Date:  2010-01-19       Impact factor: 12.701

Review 8.  The significance of the Wnt pathway in the pathology of human cancers.

Authors:  Rooshdiya Karim; Gary Tse; Thomas Putti; Richard Scolyer; Soon Lee
Journal:  Pathology       Date:  2004-04       Impact factor: 5.306

9.  A null c-myc mutation causes lethality before 10.5 days of gestation in homozygotes and reduced fertility in heterozygous female mice.

Authors:  A C Davis; M Wims; G D Spotts; S R Hann; A Bradley
Journal:  Genes Dev       Date:  1993-04       Impact factor: 11.361

Review 10.  Activation of Wnt and Myc signaling in hepatoblastoma.

Authors:  Stefano Cairo; Carolina Armengol; Marie Annick Buendia
Journal:  Front Biosci (Elite Ed)       Date:  2012-01-01
View more
  27 in total

1.  Inhibiting Glutamine-Dependent mTORC1 Activation Ameliorates Liver Cancers Driven by β-Catenin Mutations.

Authors:  Adeola O Adebayo Michael; Sungjin Ko; Junyan Tao; Akshata Moghe; Hong Yang; Meng Xu; Jacquelyn O Russell; Tirthadipa Pradhan-Sundd; Silvia Liu; Sucha Singh; Minakshi Poddar; Jayvir S Monga; Pin Liu; Michael Oertel; Sarangarajan Ranganathan; Aatur Singhi; Sandra Rebouissou; Jessica Zucman-Rossi; Silvia Ribback; Diego Calvisi; Natalia Qvartskhava; Boris Görg; Dieter Häussinger; Xin Chen; Satdarshan P Monga
Journal:  Cell Metab       Date:  2019-01-31       Impact factor: 27.287

2.  Metabolic and oncogenic adaptations to pyruvate dehydrogenase inactivation in fibroblasts.

Authors:  Huabo Wang; Jie Lu; Sucheta Kulkarni; Weiqi Zhang; Joanna E Gorka; Jordan A Mandel; Eric S Goetzman; Edward V Prochownik
Journal:  J Biol Chem       Date:  2019-02-12       Impact factor: 5.157

3.  β-Catenin mutations as determinants of hepatoblastoma phenotypes in mice.

Authors:  Weiqi Zhang; Jennifer Meyfeldt; Huabo Wang; Sucheta Kulkarni; Jie Lu; Jordan A Mandel; Brady Marburger; Ying Liu; Joanna E Gorka; Sarangarajan Ranganathan; Edward V Prochownik
Journal:  J Biol Chem       Date:  2019-10-09       Impact factor: 5.157

Review 4.  Novel Advances in Understanding of Molecular Pathogenesis of Hepatoblastoma: A Wnt/β-Catenin Perspective.

Authors:  Danielle Bell; Sarangarajan Ranganathan; Junyan Tao; Satdarshan P Monga
Journal:  Gene Expr       Date:  2016-11-02

5.  Sequential adaptive changes in a c-Myc-driven model of hepatocellular carcinoma.

Authors:  James M Dolezal; Huabo Wang; Sucheta Kulkarni; Laura Jackson; Jie Lu; Sarangarajan Ranganathan; Eric S Goetzman; Sivakama S Bharathi; Kevin Beezhold; Craig A Byersdorfer; Edward V Prochownik
Journal:  J Biol Chem       Date:  2017-04-21       Impact factor: 5.157

6.  Myc and ChREBP transcription factors cooperatively regulate normal and neoplastic hepatocyte proliferation in mice.

Authors:  Huabo Wang; James M Dolezal; Sucheta Kulkarni; Jie Lu; Jordan Mandel; Laura E Jackson; Frances Alencastro; Andrew W Duncan; Edward V Prochownik
Journal:  J Biol Chem       Date:  2018-08-07       Impact factor: 5.157

7.  Molecular Mechanisms of Hepatoblastoma.

Authors:  Yi Zhang; Antonio Solinas; Stefano Cairo; Matthias Evert; Xin Chen; Diego F Calvisi
Journal:  Semin Liver Dis       Date:  2021-01-20       Impact factor: 6.115

Review 8.  Reconciling the Biological and Transcriptional Variability of Hepatoblastoma with Its Mutational Uniformity.

Authors:  Edward V Prochownik
Journal:  Cancers (Basel)       Date:  2021-04-21       Impact factor: 6.639

9.  Genetic Dissociation of Glycolysis and the TCA Cycle Affects Neither Normal nor Neoplastic Proliferation.

Authors:  Laura E Jackson; Sucheta Kulkarni; Huabo Wang; Jie Lu; James M Dolezal; Sivakama S Bharathi; Sarangarajan Ranganathan; Mulchand S Patel; Rahul Deshpande; Frances Alencastro; Stacy G Wendell; Eric S Goetzman; Andrew W Duncan; Edward V Prochownik
Journal:  Cancer Res       Date:  2017-09-07       Impact factor: 12.701

Review 10.  The Metabolic Fates of Pyruvate in Normal and Neoplastic Cells.

Authors:  Edward V Prochownik; Huabo Wang
Journal:  Cells       Date:  2021-03-30       Impact factor: 6.600

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.